Medication info
Double Low Tablet 40/10 mg

Double Low Tablet 40/10 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
IlYang Pharmaceutical Co., Ltd.
Appearance
White or off-white oblong tablets
Packaging
30 tablets (10 tablets/Alu-Alu*3), 30 tablets/bottle
Approval status
Active

MFDS item code 201702164 · Approved 2017.04.27 · Insurance code 641705330

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, direct switching to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy have not been established in pediatric patients aged 18 years or younger; therefore, administration of this drug is not recommended.

Ingredients

Manufacturer
IlYang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This drug can effectively lower blood pressure when added to the treatment regimen of patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using amlodipine or telmisartan. It plays a critical role in improving hypertension, thereby reducing the risk of cardiovascular complications. Therefore, this medication is used for the treatment of patients with essential hypertension who have difficulty controlling their blood pressure.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, direct switching to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy have not been established in pediatric patients aged 18 years or younger; therefore, administration of this drug is not recommended.

Precautions

This drug poses a serious risk to the fetus if taken during pregnancy, especially in the second and third trimesters. It can lead to impaired kidney function in the fetus, skull formation issues, oliguria, renal failure, and in severe cases, death; thus, use during pregnancy should be avoided. This drug is contraindicated in individuals with allergies to the active or similar ingredients, pregnant or potentially pregnant women, nursing mothers, individuals with cholestatic disease, severe liver disease patients, patients with serious heart conditions, severe hypotensive patients, those in cardiogenic shock, unstable heart failure patients following acute myocardial infarction, and individuals with specific genetic issues. Use this drug cautiously in patients with primary aldosteronism or certain heart valve disorders, and those with impaired liver function. Special attention is warranted for patients with gastrointestinal or kidney diseases, particularly in those with reduced kidney function or the elderly, which may require dosage adjustments and close monitoring. Common side effects include dizziness or peripheral edema, whereas serious side effects such as syncope or cardiac issues may occur infrequently. If side effects are suspected, immediate consultation with a healthcare provider is necessary. If you are pregnant or planning to become pregnant, it is important to stop taking this medication as soon as possible and switch to another safe treatment method. Nursing mothers should also avoid this medication. This medication can interact with other drugs; therefore, be sure to inform your healthcare provider about any other medications being taken, especially lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. In the event of overdose, symptoms such as hypotension, cardiac arrhythmias, and renal failure may arise, necessitating immediate emergency treatment. Keep this medication out of reach of children and ensure it remains sealed until just before administration.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 112 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flush
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease
  • interstitial pneumonitis
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • position-related dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that effectively blocks light, as it may be sensitive to light. Additionally, it is recommended to keep the medication at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

White or off-white oblong tablets

Package unit

30 tablets (10 tablets/Alu-Alu*3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.